4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-18-054853
Chief Technology Officer sold 25,000 shares at $10.25 ($256,250)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Binder-Scholl Gwendolyn Knowlton Chief Technology Officer | 2018-08-29 | Sale | −25,000 | $10.25 | $256,250 | 0 | D |
| Open-market sales · 25,000 sh · avg $10.25 · $256,250 | |||||||
Loading xslF345X03/a4.xml…